Literature DB >> 28528955

Potential therapeutic activity of Phlogacanthus thyrsiformis Hardow (Mabb) flower extract and its biofabricated silver nanoparticles against chemically induced urolithiasis in male Wistar rats.

Poppy Das1, Kiran Kumar2, Arunai Nambiraj3, Reshma Rajan4, Rajendra Awasthi5, Kamal Dua6, Himaja M7.   

Abstract

Urolithiasis is a painful disorder in which stones are formed in the kidney, bladder or urethra. There are no proper therapeutic treatments available for kidney stones and people suffering from larger stones have to undergo surgery which has many side effects. A natural remedy with therapeutic effects that can dissipate and remove even the larger stones would eliminate the need of a surgery and the risks associated with it. The flowers of Phlogacanthus thyrsiformis used in culinary recipes in the north eastern India are also widely used as a folklore medicine for the treatment of kidney stones and liver disorders. The aim of this study was to evaluate the prophylactic and therapeutic activity of the aqueous extract of P. thyrsiformis flowers and its biofabricated silver nanoparticles against struvite urinary stones and calcium oxalate kidney stones. A kidney stone inhibition study was carried out on struvite stones grown in gel medium and calcium oxalate stones in rat models using an aqueous extract of P. thyrsiformis flowers and its biofabricated silver nanoparticles. The aqueous extract of P. thyrsiformis flowers and their biofabricated silver nanoparticles, obtained by a green synthetic method, were used to treat struvite urinary stones in vitro and calcium oxalate kidney stones in vivo. Struvite stones were grown in tubes by gel diffusion technique and were treated with varying concentrations of the extract and its nanoparticles. The size of the struvite stones was monitored for 96h using a travelling microscope. Calcium oxalate stones were induced in male Wistar rats by feeding ethylene glycol-ammonium chloride mixture for 14days. Both, prophylactic and therapeutic activities were evaluated by analyzing the urine, serum and histopathological parameters of the rats. The qualitative screening of water extract unveiled the presence of flavonoids as a major constituent. Both, the extract and the nanoparticles effectively reduced the size of struvite stones in vitro and eliminated calcium oxalate stones in Wistar rats in vivo. The potent therapeutic activity of both extract and silver nanoparticles was observed as compared to preventive activity. Anti-urolithiatic potency can be attributed to the presence of flavonoids.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calcium oxalate crystals; P. thyrsiformis; Silver nanoparticles; Struvite crystals; Urolithiasis

Mesh:

Substances:

Year:  2017        PMID: 28528955     DOI: 10.1016/j.ijbiomac.2017.05.096

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  4 in total

1.  Antiurolithic effects of medicinal plants: results of in vivo studies in rat models of calcium oxalate nephrolithiasis-a systematic review.

Authors:  Aslam Khan; Samra Bashir; Saeed R Khan
Journal:  Urolithiasis       Date:  2021-01-23       Impact factor: 3.436

2.  Salacia mulbarica leaf extract mediated synthesis of silver nanoparticles for antibacterial and ct-DNA damage via releasing of reactive oxygen species.

Authors:  Chandra Sekhar Espenti; Kummari Subba Venkata Krishna Rao; Palakurthi Ramesh; Akila Chandra Sekhar; Kummara Madhusudana Rao
Journal:  IET Nanobiotechnol       Date:  2020-08       Impact factor: 1.847

Review 3.  Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review.

Authors:  Anand Maurya; Anurag Kumar Singh; Gaurav Mishra; Komal Kumari; Arati Rai; Bhupesh Sharma; Giriraj T Kulkarni; Rajendra Awasthi
Journal:  Interv Med Appl Sci       Date:  2019-03

4.  Nephroprotective effect of Bryophyllum pinnatum-mediated silver nanoparticles in ethylene glycol-induced urolithiasis in rat.

Authors:  Revati Dighade; Ranjit Ingole; Pramod Ingle; Aniket Gade; Sunil Hajare; Maheshkumar Ingawale
Journal:  IET Nanobiotechnol       Date:  2021-03-10       Impact factor: 2.050

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.